Aldurazyme laronidase: Phase III results; BLA under review

Six-month extension data from a previously reported international Phase III trial in 45 patients with MPS I showed that Aldurazyme treatment

Read the full 219 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE